Patent · US Active

Compounds and their salts specific to the PPAR receptors and the EGF receptors and their use in the medical field

US8153841B2 · kind B2 · utility

20Cited by
14References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 24, 2006
Grant dateApr 10, 2012
Priority date
Expiry dateApr 2, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C229/42
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to compounds comprising the general formula (I), in which R1 and R2, which may be identical or different, are selected from the group comprising —H or a linear or branched alkyl group having from 1 to 6 carbon atoms or together form an aromatic or aliphatic ring with 5 or 6 atoms; Y and Z, which may be identical or different, are selected from the group comprising —H, —OH, —COOH, —OR3, —CH(OR3)COOH, in which R3 is selected from H, phenyl, benzyl, —CF3 or —CF2CF3, vinyl, allyl and a linear or branched alkyl group having from 1 to 6 carbon atoms.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.